Overview

Update
Total Equity Funding
$7M in 1 Round from 3 Investors
Most Recent Funding
$7M Series A on February 22, 2008
Headquarters:
Branford, CT
Description:
Affomix develops technology for the automated, high-throughput selection of human monoclonal antibodies.
Founders:
,
Categories:
Biotechnology
Website:
http://www.affomix.com

Company Details

Update

Affomix has proprietary technology for rapid, automated, high-throughput selection of human monoclonal antibodies (mAbs). Their mission is to commercialize proprietary mAbs, mAb microarrays and mAb libraries for research, drug discovery, diagnostic and therapeutic applications, with a particular focus on the use of their mAbs for sensitive and accurate measurement of very large numbers of proteins in biological samples.

Funding Rounds (1) - $7M

Update
DateAmount / RoundValuationLead InvestorInvestors
Feb, 2008$7M / Series A3

Current Team (1)

Update

Board Members and Advisors (1)

Update

News (1)

Update
DateNews
Dec 18, 2009VentureDeal - Affomix Corporation raises 7000000 in venture round

Offices/Locations (1)

Update
  • Office

    688 East Main Street

    Branford, CT 06405

    USA

Past Team (2)

Update

Images (1)

Update

Add Acquisitions

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos